| Code | Test Name | Description | Methodology |
|---|---|---|---|
| J001 | UGT1A1 | TA7/-3279/G71R/F83L | PCR-RFLP+ Sanger Sequencing |
| 002 | UGT1A6 | S7A/T181A/R184S | PCR-RFLP |
| J003 | Warfarin/VKORC-1 (vitamin K epoxide reductase complex, subunit 1 ) | 1639G>A | PCR-RFLP |
| J004 | Warfarin/CYP2-C9 (cytochrome P450, family 2, subfamily C, polypeptide 9) | CYP2C92(R144C), CYP2C93 (I359L) | PCR-RFLP |
| J005 | Clopidogrel/CYP2-C19 (cytochrome P450, family 2, subfamily C, polypeptide 19) | CYP2C191,CYP2C192, CYP2C193CYP2C1917* | PCR-RFLP |
| J006 | SJS (Stevens-Johnson syndrome) / HLA-B1502 for Carbamazepine | genotype for HLA-B1502 | Nested-PCR |
| J007 | SJS (Stevens-Johnson syndrome)/ HLA-B 5801 for Allopurinol | genotype for HLA-B580 | Nested-PCR |
| J009 | TMPT (Thiopurine S-Methyltrans-ferase) gen | TMPT direct sequencing for 8 exons | Sanger Sequencing |
| J010 | SLCO1B1 Variant for Statin | rs4149081 and rs4149056 | PCR-RFLP / AS-PCR |
| J011 | Pharmacogenetics Package | CYP2-C19, VKORC-1, HLA-B1502, CYP2-C9, HLA-B5801, SLCO1B1, UGT1A128/UGT1A66, TMPT | Various molecular method |
| J013 | CYP2D6 | CYP2D62 (rs16947), CYP2D64 (rs3892097), CYP2D6*10 (rs1065852) | Sanger Sequencing |
| V055 | HLA- B27 Genotyping for Ankylosing Spodylitis and Related Conditions | Detection of the surface protein human leukocyte antigen B27 (HLA-B27) of white blood cells | PCR |
